E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/12/2006 in the Prospect News Biotech Daily.

Bovie Medical files FDA application for GI device as second-quarter revenues grow

By Lisa Kerner

Charlotte, N.C., July 12 - Bovie Medical Corp. said it filed a 510(K) application with the Food and Drug Administration for its GI ICON device, an electrosurgical product for the gastroenterological market.

The GI ICON includes a touch screen interface, physician preference database, neutral electrode monitoring, and common sense messaging.

"We are poised to enter a growing GI market where statistics indicate that the number of colonoscopies performed in the United States is increasing at a dramatic rate," president Andrew Makrides said in a company news release.

In addition to the FDA filing, the company announced it is expecting to report in August that its second quarter was the highest revenue quarter in Bovie's history.

Bovie, located in Melville, N.Y., manufactures and markets electrosurgical products.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.